A Missouri state lawmaker has filed legislation that would dramatically reshape how hemp-derived cannabinoid products are regulated in the state, effectively folding much of the intoxicating hemp market into Missouri’s existing marijuana framework.
House Bill 2641, filed today by State Representative Dave Hinman (R), would repeal and replace portions of Missouri’s controlled substances law while creating several new statutory sections focused on cannabis, patient privacy and hemp-derived products. Taken together, the proposal would significantly restrict the sale of intoxicating hemp-derived THC products outside the state’s licensed marijuana system.
One section of the bill would prohibit state agencies from sharing identifying information about medical marijuana patients or caregivers with the federal government or unauthorized third parties, except when required by a subpoena or court order. Knowingly violating that provision would be classified as a felony under the proposal.
Another provision would allow marijuana dispensaries to avoid creating or retaining records containing a consumer’s identifying information if the consumer requests it in writing. That section would not apply to recordkeeping requirements tied to medical marijuana patients and caregivers under Missouri’s constitution, but dispensaries that violate the consumer request provision could face fines for each occurrence.
The most consequential portion of the legislation is a new section titled the “Intoxicating Cannabinoid Control Act.” Under that framework, many hemp-derived cannabinoid products currently sold outside licensed marijuana dispensaries would be treated as marijuana under state law. The bill declares that Missouri has a compelling interest in subjecting hemp-derived intoxicating products to regulatory standards that are no less stringent than those applied to marijuana businesses.
If enacted, the bill would require that cultivation, manufacturing, testing, transportation and retail sales of hemp-derived cannabinoid products be conducted only by entities licensed under Missouri’s constitutional marijuana program. Those products would fall under the same regulatory authority that oversees licensed marijuana facilities, with enforcement shared among state agencies and the attorney general’s office.
The legislation draws a clear distinction between non-intoxicating hemp and hemp-derived products that contain or are marketed for intoxicating effects. It would exclude traditional industrial hemp, non-cannabinoid hemp products and compliant hemp used for fiber, grain, seed or research purposes. Interstate transportation of lawful hemp would remain allowed, and the bill states it is not intended to conflict with federal hemp law.
Penalties for violations would be substantial. Selling or handling hemp-derived cannabinoid products outside the licensed marijuana system could result in significant fines per transaction and felony charges. The bill would also prohibit businesses that are not licensed marijuana dispensaries from using the term “dispensary,” or similar language, in their business names.
Notably, the legislation includes a delayed effective date for key provisions, with changes tied to the controlled substances definitions and hemp-derived cannabinoid section not taking effect until November 12, 2026, around the time a federal change in hemp laws is set to take effect. The bill also includes a contingency clause that would roll back many of the new restrictions if intoxicating hemp-derived products are explicitly legalized under federal law.
